
Neurocrine Biosciences Inc
NASDAQ:NBIX

Wall Street
Price Targets
NBIX Price Targets Summary
Neurocrine Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
NBIX
is 160.68 USD
with a low forecast of 116.15 USD and a high forecast of 201.6 USD.
Operating Income
Forecast
Operating Income Estimate
Neurocrine Biosciences Inc
For the last 13 years the
compound annual growth rate for
Neurocrine Biosciences Inc's operating income is
24%.
The projected
CAGR
for the next 3 years is
22%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NBIX's stock price target?
Price Target
160.68
USD
According to Wall Street analysts, the average 1-year price target for
NBIX
is 160.68 USD
with a low forecast of 116.15 USD and a high forecast of 201.6 USD.
What is Neurocrine Biosciences Inc's Revenue forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Neurocrine Biosciences Inc's revenue is
30%.
The projected
CAGR
for the next 3 years is
14%.
What is Neurocrine Biosciences Inc's Operating Income forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Neurocrine Biosciences Inc's operating income is
24%.
The projected
CAGR
for the next 3 years is
22%.
What is Neurocrine Biosciences Inc's Net Income forecast?
Projected CAGR
35%
For the last 13 years the
compound annual growth rate for
Neurocrine Biosciences Inc's net income is
18%.
The projected
CAGR
for the next 3 years is
35%.